Axsome Therapeutics (AXSM): O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Depressiya va migren terapiyalariga bo'lgan barqaror talab Axsome Therapeutics (AXSM) uchun uzoq muddatli barqarorlikni kafolatlaydi. Innovatsion blokbasterlar kompaniyaga global neyrofarmakologiya bozorini tezlik bilan egallash imkonini beradi, shuningdek, shartnomaviy ishlab chiqarish orqali kengayish ishonchli operatsion asosni ta'minlaydi. EPS dinamikasiga nisbatan P/E koeffitsiyenti kotirovkalarning ishonchli barqarorlashganini ko'rsatadi, bunda ushbu ko'rsatkich 0.00 darajasida bo'lib, bu aktivning adolatli qiymatini aniqlashga yordam beradi.
Axsome Therapeutics (AXSM) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya narxi va konsensus maqsadli narx:
- birja kapitallashuvi ma'lumotlari:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Qarzning kapitalga nisbati Axsome Therapeutics|AXSM - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati axsome.com|AXSM - Kompaniyaning umumiy qarzi|Qarzning balans kapitaliga nisbati Axsome Therapeutics Inc|AXSM - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli kredit va qarzlari Axsome Therapeutics|Shoshilinch likvidlik axsome.com
- foyda va multiplikatorlar bo'yicha ma'lumotlar:
AXSM - Kompaniyaning sof foydasi|Kutilayotgan sof daromad Axsome Therapeutics|AXSM - P/E multiplikatori|Forvard P/E multiplikatori Axsome Corp|AXSM - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniya qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Axsome Therapeutics Inc|AXSM - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Axsome Therapeutics|AXSM - So'nggi 12 oy davomida bir aksiya uchun sof foyda|Choraklik EPS foyda o'sishi axsome.com|AXSM - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning prognoz qilingan ortishi Axsome Therapeutics
Kompaniyaning jamlanma tahliliyoti:Axsome
PEG koeffitsiyenti P/E ko'rsatkichi bilan foyda o'sish sur'atlarini taqqoslaydi, bu esa aktivning adolatli qiymatini uning dinamikasiga asoslanib aniqlash imkonini beradi. Joriy P/E-o'sish nisbatini tahlil qilish orqali investor Axsome Therapeutics (AXSM) kompaniyasining neyrofarmatsevtika va migren segmentlariga agressiv kengayishi uning kapitalizatsiyasini qanchalik samarali oqlashini ko'rishi mumkin, bunda birdan past qiymatlar kompaniyaning salohiyati sezilarli darajada past baholanganligidan signal hisoblanadi.
Raqobatdosh kompaniyalar
Biogen Inc - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Neurocrine Biosciences Inc NBIX|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Regencell Corp (RGC)|ACAD - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda xenon-pharma.com|Viking Therapeutics, Inc. (VKTX) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Supernus Pharmaceuticals, Inc.|CPRX (Catalyst Pharmaceuticals Inc) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Denali Corp DNLI|Narx-foyda va o‘sish multiplikatori HRMY (Harmony Biosciences)|BHVN (biohavenpharma.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Amylyx Pharmaceuticals, Inc. - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati TRVI (Trevi Therapeutics Inc)|Praxis Medicines - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti AVXL (Anavex Life Sciences Corp)|CBLL: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Prothena (PRTA)|Narxning foydaga va o‘sish sur’atiga nisbati Alector Inc.|ANNX: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori OMER|PEG multiplikatori Neurogene Therapeutics (NGNE)|Narxning foydaga va o‘sish sur’atiga nisbati AC Immune ACIU|VYGR (voyagertherapeutics.com) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Neumora Therapeutics, Inc. - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Scilex Holding|TVGN (Tevogen Bio Holdings, Inc.) - Narx-foyda va o‘sish multiplikatori|Alpha Cognition Inc. (ACOG) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori CGTX|IKT (inhibikase.com) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori SAVA|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati assertiotx.com|PEG multiplikatori COYA (Coya Therapeutics)|VTGN - Narx-foyda va o‘sish multiplikatori|OVID - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati acumenpharm.com ABOS|CRVO: PEG multiplikatori|Alterity Therapeutics Limited (ATHE) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori CLNN|O‘sishni hisobga olgan narx-foyda koeffitsiyenti PEPG (PepGen Corp)|Narxning foydaga va o‘sish sur’atiga nisbati Jupiter Neurosciences Inc (JUNS)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati relmada.com|Narxning foydaga va o‘sish sur’atiga nisbati Annovis Bio ANVS|GRCE - Narx-foyda va o‘sish multiplikatori|AIFF - Narxning foydaga va o‘sish sur’atiga nisbati|KLTO (Klotho Neurosciences Inc) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|NRSN: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda revivapharma.com (RVPH)|Narx-foyda va o‘sish multiplikatori MTVA|PEG multiplikatori NeurAxis Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Helius Medical (HSDT)|PASG (passagebio.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Neuphoria Therapeutics NEUP|minervaneurosciences.com (NERV) - O‘sish sur’atiga tuzatilgan narx-foyda|Athira Pharma - PEG multiplikatori|ADXN - PEG multiplikatori|ALZN (alzamend.com) - Narx-foyda va o‘sish multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti CYCN|Narxning foydaga va o‘sish sur’atiga nisbati Protagenic Therapeutics Inc.|Pasithea (KTTA) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Cortigent, Inc. (CRGT)|ATXI - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Brainstorm Cell Therapeutics, Inc. BCLI|CARA - Narx-foyda va o‘sish multiplikatori|Chromocell Therapeutics - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Eliem Therapeutics|ITCI (intracellulartherapies.com) - Narx-foyda va o‘sish multiplikatori|Longboard Pharmaceuticals Inc - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori MRNS|NKGN (NKGen Biotech Corp) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori NRBO|SAGE (sagerx.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori SNPX (Synaptogenix)|Trevena Inc. (TRVN) - O‘sish sur’atiga tuzatilgan narx-foyda|VIGL - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti WENA (Anew Medical Inc.)|CERE: PEG multiplikatori
